Pharmaceutical Published Insights

Published Date : 02 Apr, 2026

Global intravenous (IV) ibuprofen market is estimated to be valued at USD 7.96 Bn in 2026 and is expected to exhibit a CAGR of 7% during the forecast period (2026 - 2033). Intravenous (IV) ibuprofen is used for pain relief and fever reduction for several decades. As... View more

Published Date : 02 Apr, 2026

The global gastric motility disorder drug market is estimated to be valued at USD 64.41 Bn in 2026 and is expected to exhibit a CAGR of 5.8% during the forecast period (2026 - 2033). Gastric motility disorder refers to conditions wherein the stomach takes more or le... View more

Published Date : 02 Apr, 2026

Global non opioid pain treatment market is estimated to be valued at USD 93.57  billion in 2026 and is expected to reach USD 171.04 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033. Ri... View more

Published Date : 02 Apr, 2026

The medical second opinion market is estimated to be valued at USD 9.69 Bn in 2026 and is expected to reach USD 28.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.7% from 2026 to 2033. The global medical se... View more

Published Date : 02 Apr, 2026

Global cosentyx drug market is estimated to be valued at USD 6.16 Bn in 2026, and is expected to reach USD 10.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033. Cosentyx (secukinumab) is a... View more

Published Date : 02 Apr, 2026

The Lenalidomide Drug Market is estimated to be valued at USD 15.04 Bn in 2026 and is expected to reach USD 23.83 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. Lenalidomideis an immunomo... View more

Published Date : 02 Apr, 2026

Leber congenital amaurosis (LCA) is a group of inherited retinal diseases causing severe visual impairment from birth. It is characterized by poor vision, nystagmus, and potentially blindness. LCA is typically caused due to mutations in genes responsible for photorece... View more

Published Date : 02 Apr, 2026

Cold sores, also known as fever blisters or oral herpes, are small, fluid-filled blisters that form around or inside the mouth. These are most commonly caused by the Herpes simplex virus type 1 (HSV-1). Global cold sore treatment market growth is driven by rising prev... View more

Published Date : 02 Apr, 2026

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in... View more

Published Date : 02 Apr, 2026

Global leuprolide acetate market refers to the pharmaceutical market for leuprolide acetate drugs, which is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). Leuprolide acetate is used as a medication to treat prostate cancer... View more

Published Date : 02 Apr, 2026

Global camylofin market offer huge opportunities for market players due to its wide range of therapeutic applications. Camylofin is a promising pharmaceutical compound that is used for treatment of anxiety, insomnia and depression. There has been increase in prevalenc... View more

Published Date : 02 Apr, 2026

The Global Exosomes Skincare Market is estimated to be valued at USD 460.0 Mn in 2026 and is expected to reach USD 819.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033. Exosomes are extracellula... View more

Published Date : 02 Apr, 2026

The Global Somatic Therapy Market is estimated to be valued at USD 4.72 Bn in 2026 and is expected to reach USD 12.55 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.32% from 2026 to 2033. The global somatic therapy market has been witnessing ste... View more

Published Date : 02 Apr, 2026

The Global Behavioral Therapy Market is estimated to be valued at USD 204.28 Bn in 2026 and is expected to reach USD 335.12 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033. The global behavioral t... View more

Published Date : 02 Apr, 2026

The Global Noonan Syndrome Market is estimated to be valued at USD 1.21 Bn in 2026 and is expected to reach USD 2.13 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033. Noonan syndrome is a rare gene... View more

Published Date : 01 Apr, 2026

Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manner. The market of bo... View more

Published Date : 01 Apr, 2026

The global sulfonamides market is estimated to be valued at USD 150.3 Mn in 2026 and is expected to reach USD 218.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033. The ... View more

Published Date : 01 Apr, 2026

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development a... View more